Detailed price information for Ars Pharmaceuticals Inc (SPRY-Q) from The Globe and Mail including charting and trades.

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than ...

There are plenty of different schools of thought on the matter, but the truth depends on what type of car you have.

The patented Aerio™ platform was designed to meet the highest standards of device function and form from food allergies to ...

Global Pen Needles Market OverviewThe global pen needles market is projected to grow at a robust CAGR of 9% over the next five years. This growth is primarily driven by the rising prevalence of ...

Neffy needle-free epinephrine spray sales surge, global expansion, and CSU Phase 2b upside. See more on SPRY here.

It is unclear what the company intends to charge for the vials, the report said. ・Unlike Novo, Eli Lilly and Company already ...

Five poster presentations highlight clinical advancement of neffy, real-world usability and advantages of needle-free epinephrine delivery ...

Five poster presentations highlight clinical advancement of neffy , real-world usability and advantages of needle-free epinephrine ...

CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) DIJON, France - February 2, 2026 (7:15 a.m. CET) – CROSSJECT (ISIN: FR0011716265; Euronext: ALCJ), the ...

Intas Pharmaceuticals has entered into an exclusive agreement with IntegriMedical, the technology leader behind India’s first needle-free injection system (N-FIS), to introduce this revolutionary ...